Twin Capital Management Inc Catalent, Inc. Transaction History

Twin Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$94.19 - $124.49 $398,423 - $526,592	-4,230 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$119.57 - $139.07 $39,458 - $45,893	-330 Reduced 7.24%	4,230 $542,000
Q3 2021 Oct 29, 2021	BUY	$109.17 - $142.35 $4,366 - $5,694	40 Added 0.88%	4,560 $607,000
Q2 2021 Aug 09, 2021	SELL	$100.34 - $115.69 $2,006 - $2,313	-20 Reduced 0.44%	4,520 $489,000
Q1 2021 May 06, 2021	BUY	$101.51 - $125.27 $460,855 - $568,725	4,540 New	4,540 $478,000

489

165M

364K

837K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Twin Capital Management Inc with notifications on news.